mo Th Use ,Ad fet.
ANS
and mo*} O du s wrd in of AG
Neme
Tamsul odin and
ClasifiCoi (cmplete f t )
C E o-Hropie f
er
A od. ffe oflouma.tant lete
Py amalbg ue
in 1
OP PoOyn
me
Propanalo)
duantie and its
7athy pylaxis.
Atehol8
beyii a ye oluo p in Ulaveom
Latano pro r
pharma.
2
E in BPH Thera r 7
113 Lole of- Hypet tnstm w.
Aclr. nD voee in f a
j Néostiamint
5. pAsst amine
T6. nelena
Sicene.
moHon
catedl in
. A n g l e . G l a u c m a
cauPine.ii ndi c e r t u n ond
Cxplain w Pils Saun9 Drug- in
diyfunc
2.Adr S i e Bladder
is wed in Carba matc peiain
3. Frawoxate, oP a n cd not
ime o c for k
af of6PH
y. Pralicloeloy over fra2oin for k
i n fA preftvred
5. Tameul inalauem
Tmlel f e d prefpd ouenptlolaupine
6 n d n o t Nca ti.mine
infHropi ne pidiming
yso, -Arle Glaucom
8La-tanopr
iJ e o l inwde icjened.
i ed for m o t i
9. Seopo lamne in K oBPH
hmsin wed
(. Tamso
m e d tn G lavtoha.
diabetie p
2. i n
13. AAYopine con leac do yelopaa
nAnoptylah'e no
ce
1. Adr. be
be noed in/uthn2y
necd in/uithin ?hr
s
Leäctivartrs Should
5 . CelineHuage
16. AAro Pine is uoe
d in 6 Pe idining.
Deouar2ohion Neostiamine
is woed alm9uuth atopine
9 for Hyptrthermia,
w e d in malanant
46d.
18. antrsltnt
Respiretary Cae producive Couh.
used rn produeive
Couh
areAdnm'nittered Before, inhalatieal
mweoti,
.
Aplain why
-
Cortotteubel
muth S t t a AsthmaHe
Brmno|atur
n paienti
A%thma
monde l u t o t in KrnCni al
3 uiee f
for 44 of, r couJ h on.
Coeltine ù uoed
LL. of Bnial fHno
tihiHaminit not Effeiue afor
aue
5.
t ue maintay a
mainda
As and2
6. Clu tstortttsiH w a
tmma
Byo n
.iotropfum
Dextro methophara
Statuo thnmatiet
-mo moA and
and S
detongtHarh.
N a Closificotiom Dru9
. 8 r m n al Mtma
G mb A
.
CAinical Steato,.:
mosleuoly ttptre fithW
chronic Brondt3.
AntiCholer e
art. prefftyed in
P Sensna),-tnma. mt, e , wwea
n mtthyl Xantheie
Bromhexi e
1
12
Exylain wy 1. m1ag.
cmd Af. SalH
are
Co mbjneel an Artatid prep.
T
melalazine 1 ed on 0
Cooteel o r Delay eod pe)aage
Prep in bc
Can cauye prol9 and Complete tuppreestan
3. omtpra2ale
Aid t a n donitiYine./fam,ine
of Cantrie
Should be done in pat. a rptie ole
4. Kf H.pori int.
e d in HPori tn
5. Dg Cembinati
td a -Aniallerie duug
6. Ranitidine NAAID Ind. Peptie
uleer
eel fr f. f
. mido proito| Cyneco mutia
. metiaine cCan caelt Coma encephalopathy
lactuloie ii wed in Heputi
9.
ComPlete)
Ondansetvon ( closifichdion of Dr
I.
Pepti ulcer
mo
Lmo u e , A1e
3. Dieclemi ne.
PP1>(cemylett)- mepra2elekabeprazele
. HPyler eraolitation aimen and ondansetron
GytopYolate
Lationale. of
G pre ama tythetie
mtoclopramide
"blee
suerafte in Th: of feptie"
Fole f
.
FRfenadine preftweel dvlrthlonpnenira
mint
Auto toid- Explain w
pruyi
S P i n my be dii tonth weel
2. w e e ll pri'or td
iven in chrenie
Gout
Allbpuune a r l i t r t h a n analgic oun
a t o n As pivin 34art
4, Antiatlt Doe
a -Antipldelet og
low
5 As pirin ued i
1. Probenetd
TraTra madls)
Alopuuo)
4 buproen -
Cdipicodion
Drug
5 rihist+aminie,
mooliert
6. Role af CT ArthriHa.
HHatl bf Goity
D for h u t t
n PA
Ule o mty
DmARD
D Gen-AnH-hiHa minjes
6ver
StCyen
1" Gen
Adv rt Anthd ota
Pm -toxiecty and
1. meth
2 nclemethoii
13. US o h mti hita minjs
15. NIAID-CliPlention
l6. pem- met, , 1 e , foisisming.
19 Sechve Coy 2
t C1 to Spinal Ahgentheia
noctheties-Expbin w ed a L
. L g n ocajne fenal dy
t n hpaha
or
prferrel poet in
fr infecteol ttrea
3.HanCuuuium i needed ffrinfectd
r
DoJe of Ligno
teine Sodium
L. Lar
4. targe
Aing
hinpentonc
AGim
th C
5. UHra hort meolieatonA Mecl alomg A
6pre
gnesthie
r
Tnductiom o
to tiopental
cctamine Prtfvred
t.eetamine
pre Anauthetic Aaenti.
Ligno caine
. a v to a LA
ad. ofAdling
5- Spina Anaethtia
iseA
ónipketo)
LeleNantH
CI
mustue
Phtrto lamine.
rale peridlo) prefpeutol-drufor A t sthbophrenig
morptnine ch in Pot Head tngury Bz.0
over
L A1pra2otam prrferred for Angicty
Dop and not Dspqmine wwed in h of Parkjnor
20t abirbed Py frmach,
6. Mpmne dulmate
DiJuWfram
1e. n t toltrort ed ayer
aut not in rouetine
Pa2epam med
8. n status Qpileptiwn
ThFer aPr\p'y.
Ao i n pot t
Seegr line is priferred to otner
arinsomi m
over Barbrtmote a edati've tapotiu
18. Bap prperrtel
mbino ith Corbidl1pa
1 LD0pa 's
12 DoPamine vwt in ed/oenie thocle
3. mcthaelme in l of morpne
ed adlls
7 . Orva mmrttin achais te or pdt in Th:
n n t h t i c f o r painles
Bupi vatuine prtftrid epiolunel
ollvert Ane pO Amug en,
n to L-PopPa
6, t id Aelu to adol DeCaubolase O
î'n o f Paue'mth
l n DhP L Popq not Do
m9 y
mi pram1ne
8. umatriPtan
poid Antgsa
G Ne AvtiapitetHe pnus
. StPiH'
mi'ne.
D oDo pe
14. Dia2eMm.
1. poyi oisi ina.
prioiing.
12 m t l Me: m fier km
13. vgo Ceuminy DNufira
Sod. voproatt moA w, W
Antipilpthe Dru -Clomiplcion
mirtazapint
Stctuo Qpiltphona.
Aypi ca AntiSy Cotica,
20. Couroma2ePIne."
21. fo o {eere m Me.
to 4 bPioI Di and B20 overdn c
Dru
23. ToXu of vinca allcaloidls
auato be
en.phey nMg- , evplan wny .
Dnugs uth naou 7h: mamg1h
mdnrtored at eular nt'rvota
orcler en otico
hawe ngrrdw emH
Dru fo||buing 2ero
Tpnm
3. ome Drug Feq.
Biocvalability
&. 2ero o rltr nctfes.
Etngial Drug Concept
L Teratogen ity of Drugs
5 Drug Atajeim
En2me Hon
Rainale ru woe
8 Traeder ma Th y
. eceptor fegulatin
Plmm and einical sianfica ncr
l o r d t r incHe Lohy"
Voious Drug e w rd for Cüni cal
(2 PAtmt
oFug.
3. FaCtord eching olotoladv.
Adv. ovno
F
Atiem
mmocA 8f prologatiom oforug
irs pa metab
18 Plaktau prmupl. tmplícoution
Cuical
mierema rug infectiom-
1 on, modf
attors mpeuPy Drug
(oeliae elus o d hyaud Hetne
Hdw LAT PF 7,
i t h xa mPle
Dru 4a
in meolèine.
2. Pole af placebo
ole of Glocon
2 OLS uw Ha formmla.
Nw
Snifcance.
Dtbuh'm md its cunal
23
vol. oP in In dla
ptMon rnatol a nte
pro
24.
25 CPcR
NCanprticdes.
6
